Church & Dwight Co. (CHD)
(Delayed Data from NYSE)
$102.16 USD
-0.48 (-0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $102.11 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$102.16 USD
-0.48 (-0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $102.11 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Keurig Dr Pepper (KDP) Q2 Earnings Top Estimates, Sales View Up
by Zacks Equity Research
Keurig Dr Pepper's (KDP) second-quarter 2023 results reflect increases in sales and earnings, driven by continued brand strength and significant pricing.
Why Earnings Season Could Be Great for Church & Dwight (CHD)
by Zacks Equity Research
Church & Dwight (CHD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors Likely to Influence Diageo's (DEO) FY23 Earnings
by Zacks Equity Research
Diageo's (DEO) fiscal 2023 results are expected to reflect gains from its effective marketing, strong commercial execution and favorable industry trends of premiumization.
Is a Beat in Store for Molson Coors (TAP) in Q2 Earnings?
by Zacks Equity Research
Despite inflation, Molson Coors' (TAP) second-quarter results are expected to reflect strength in core brands, a revitalization plan and the premiumization of its global portfolio.
Altria Group (MO) Queues for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Altria Group's (MO) second-quarter results are likely to reflect gains from pricing and strength in Oral Tobacco Products, though soft cigarette volumes have been a concern.
What to Note Ahead of Service Corp's (SCI) Q2 Earnings?
by Zacks Equity Research
Service Corp's (SCI) second-quarter 2023 performance is likely to have been affected by inflationary pressure. Strength in the preened cemetery sales has been an upside.
Factors to Note Ahead of Sysco Corporation's (SYY) Q4 Earnings
by Zacks Equity Research
Sysco's (SYY) fiscal fourth-quarter earnings is likely to reflect gains from the Recipe for Growth initiative. However, rising cost inflation might have been a hurdle.
Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.
Albertsons (ACI) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Albertsons' (ACI) fiscal first-quarter results showcase the robustness of its business and the success of the Customers for Life transformation strategy amid increasing economic challenges.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Procter & Gamble (PG) is Poised for Q4 Earnings Beat
by Zacks Equity Research
Procter & Gamble's (PG) unwavering commitment to leverage its brand strength and adopt effective strategies has been bolstering its organic sales and market position.
Will Church & Dwight (CHD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Colgate (CL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) second-quarter 2023 sales are likely to have benefited from strong demand for its products, innovation, brand strength and a focus on premiumization. Rising costs and expenses might have hurt its margins.
Factors Likely to Decide Newell's (NWL) Fate in Q2 Earnings
by Zacks Equity Research
The ongoing tough environment, reduced inventory and inflationary pressures are likely to have dented Newell's (NWL) Q2 earnings despite productivity and efficiency initiatives.
Factors to Note Ahead of FEMSA's (FMX) Upcoming Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q2 results are expected to reflect gains from continued strength in OXXO Mexico and OXXO Gas, expansion into newer businesses, and digital initiatives amid cost woes.
Will Soft Shipment Trend Mar Boston Beer's (SAM) Q2 Earnings?
by Zacks Equity Research
Boston Beer's (SAM) Q2 results are expected to reflect the continued impacts of declining shipments and depletions, and challenges in the hard seltzer category.
Mondelez (MDLZ) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Mondelez's (MDLZ) second-quarter 2023 performance is likely to gain from effective pricing actions and prudent buyouts. Strength in the company's snacking category is an upside.
Is a Beat in Store for Church & Dwight (CHD) in Q2 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter results are likely to reflect gains from pricing, innovation and demand amid elevated costs.
The Hershey Company (HSY) Queues for Q2 Earnings: What Awaits?
by Zacks Equity Research
The Hershey Company's (HSY) second-quarter results are likely to reflect gains from pricing and innovation. Prudent buyouts have also been a driver.
Church & Dwight (CHD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pilgrim's Pride (PPC) Queues for Q2 Earnings: What's in Store?
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter results are likely to reflect the impacts of cost inflation, while customer-centric initiatives and solid foodservice demand bode well.
Is a Beat in Store for Kimberly-Clark (KMB) in Q2 Earnings?
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter results are likely to reflect gains from revenue management efforts and strategic growth pillars amid cost inflation.
Clorox (CLX) Gains From Digital Initiatives & Pricing Power
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy serves as a catalyst for driving innovation, enhancing operational efficiency and bolstering international growth.
Procter & Gamble (PG) Widens Spectrum on Value Creation
by Zacks Equity Research
Procter & Gamble (PG) advances the execution of the integrated strategies -- Supply Chain initiatives and digital penetration to strengthen the organization.
3 Stocks to Buy for Decreased Volatility
by Derek Lewis
With CPI looming, investors may want to visit low-beta stocks as a shield against volatility. As we all know by now, CPI days have become quite a market-moving event.